The Study
Targeting Senescence with Apigenin Improves Chemotherapeutic Efficacy and Ameliorates Age‐Related Conditions in Mice
This study tested a plant chemical called apigenin in mice and lab-grown cells to see if it could reduce inflammation from old cells. It found that when they gave apigenin to sick mice, they seemed to move better and remember things better. But it didn't test this in people, and we can't say for sure the chemical caused the improvement.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
Apigenin is a natural compound in plants that doesn't kill old, damaged cells but stops them from sending out harmful inflammatory signals.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 514 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—this means older or chemo-treated bodies could function better and fight cancer more effectively by calming inflammation from old cells.
- 2In mice, apigenin reduced tumor growth by 74.9% when given with chemo, improved grip strength, endurance, balance, and memory, and reduced anxiety—all without killing cells or causing side effects.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Advanced Science
Year
2025
Authors
Hongwei Zhang, Qixia Xu, Zhirui Jiang, Rong Sun, Qun Wang, Sanhong Liu, Xin Luan, Judith Campisi, J. Kirkland, Weidong Zhang, Yu Sun
Related Content
Videos (1)
Claims (9)
Of 66 natural compounds tested, only apigenin reduced the gene expression pattern linked to cellular aging without killing the aged cells.
Apigenin reduces the release of inflammatory signaling molecules IL-6, IL-8, and CXCL10 from aged, non-dividing cells.
In mice treated with chemotherapy, adding apigenin to mitoxantrone reduces tumor growth by 74.9% compared to no additional treatment, by blocking signals from surrounding cells that make the cancer resistant to the drug.
Apigenin does not eliminate senescent cells or lower levels of p16INK4a and p21CIP1 proteins, but it reduces the release of inflammatory molecules from these cells, distinguishing it from agents that kill senescent cells.
In mice exposed to radiation, apigenin reduces cellular senescence signals, resulting in better physical performance and memory, with no signs of harm to the body.
Apigenin directly interacts with the protein PRDX6 to block its enzymatic function, which stops a specific signaling pathway responsible for cellular senescence.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.